Basu, B., Erdmann, S., Sander, A., Mahapatra, T. K. S., Meis, J., & Schaefer, F. (2023). Long-term efficacy and safety of rituximab versus tacrolimus in children with steroid dependent nephrotic syndrome. Kidney international. Reports, 8(8), . https://doi.org/10.1016/j.ekir.2023.05.022
Chicago-Zitierstil (17. Ausg.)Basu, Biswanath, Stella Erdmann, Anja Sander, Tapan Kumar Sinha Mahapatra, Jan Meis, und Franz Schaefer. "Long-term Efficacy and Safety of Rituximab Versus Tacrolimus in Children with Steroid Dependent Nephrotic Syndrome." Kidney International. Reports 8, no. 8 (2023). https://doi.org/10.1016/j.ekir.2023.05.022.
MLA-Zitierstil (9. Ausg.)Basu, Biswanath, et al. "Long-term Efficacy and Safety of Rituximab Versus Tacrolimus in Children with Steroid Dependent Nephrotic Syndrome." Kidney International. Reports, vol. 8, no. 8, 2023, https://doi.org/10.1016/j.ekir.2023.05.022.